Lymphocyte alveolitis in HAM/TSP patients: preliminary report

Mattos, K.; Queiroz, C.; Peçanha-Martins, A.C.; Publio, L.; Vinhas, V.; Melo, A.

doi:10.1590/S0004-282X1993000100022

Abstracts

HTLV-I associated myelopathy has been described as a systemic disease characterized by manifestations in several organs outside the nervous system. We report inflammatory pulmonary involvement in patients with diagnosis of HAM.

HTLV-I; HAM; alveolitis; pulmonary involvement

Mielopatia por HTLV-I (HAM) tem sido descrita como doença sistêmica caracterizada pelo acometimento de vários órgãos além do sistema nervoso. Neste registro, estamos relatando o envolvimento pulmonar em pacientes com HAM.

HTLV-I; HAM; alveolite; acometimento pulmonar

K. Mattos; C. Queiroz; A.C. Peçanha-Martins; L. Publio; V. Vinhas; A. Melo

Federal University of Bahia (UFRA), Salvador

SUMMARY

HTLV-I associated myelopathy has been described as a systemic disease characterized by manifestations in several organs outside the nervous system. We report inflammatory pulmonary involvement in patients with diagnosis of HAM.

Key words: HTLV-I, HAM/TSP, alveolitis, pulmonary involvement.

RESUMO

Mielopatia por HTLV-I (HAM) tem sido descrita como doença sistêmica caracterizada pelo acometimento de vários órgãos além do sistema nervoso. Neste registro, estamos relatando o envolvimento pulmonar em pacientes com HAM.

Palavras-chave: HTLV-I, HAM/TSP, alveolite, acometimento pulmonar.

Full text available only in PDF format.

Texto completo disponível apenas em PDF.

Aceite: 25-setembro-1992.

Dr. Ailton Melo Departamento de Neuropsiquiatria, Faculdade de Medicina, UFBA Av. Reitor Miguel Calmon s/n 40110-100 Salvador BA Brasil. Fax (071) 2458562.

1. Akizuki S, Nakazato O, Higuchi Y, Tanabe K, Setohushi M, Yoshida S, Miyasaki Y, Yamamoto S, Sudou S, Sannomiya K, Okajima T. Necropsy findings in HTLV-I associated myelopathy. Lancet 1987, 1:156-157.
2. Gesaain A, Vernant JC, Maurs L, Barin F, Gout O, Calender A, De Thé G. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
3. Grimaldi LM, Roos RP, Devare SG, Casey IM, Maruo Y, Hamada T, Tashiro K. HTLV-I associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p21 antibodies. Ann Neurol 1988. 24:727-731.
4. Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE. Immunological studies in tropical spastic paraparesis. Ann Neurol 1990, 27:149-156.
5. Meireles A, Moreira ED Jr, Moreno-Carvalho OA, Badaró R, Melo A. HTLV-I associated myelopathy in Salvador (northeastern Brazil). Arq Neuro-Psiquiat (São Paulo) 1992, 50:189-190.
6. Melo A, Moura L, Rios S, Machado M, Costa G. Magnetic radiologic imaging in HTLV-I associated myelopathy. Arq Neuro-Psiquiat (São Paulo) 1992, submitted.
7. Osame M, McArthur JC. Neurologie manifestation of infection with human T cell lymphotropic virus type I. In Asbury AK, McKhann GM, McDonald WI (eds): Diseases of the nervous system: clinical neurobiology. Philadelphia: Saunders, 1992, 1331-1339.
8. Roman GC. The neuroepidemiology of tropical spastic paraparesis. Ann Neurol 1988, 23 (Suppl):113-130.
9. Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Kawasaki S. T-lymphocyte alveolitis in HTLV-I associated myelopathy. Lancet 1987, 2:1220.

Lymphocyte alveolitis in HAM/TSP patients: preliminary report

Alveolite a linfócitos em pacientes com HAM/TSP: registro preliminar

Publication Dates

Publication in this collection
19 Jan 2011
Date of issue
Mar 1993

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

[1] 1. Akizuki S, Nakazato O, Higuchi Y, Tanabe K, Setohushi M, Yoshida S, Miyasaki Y, Yamamoto S, Sudou S, Sannomiya K, Okajima T. Necropsy findings in HTLV-I associated myelopathy. Lancet 1987, 1:156-157.

[2] 2. Gesaain A, Vernant JC, Maurs L, Barin F, Gout O, Calender A, De Thé G. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.

[3] 3. Grimaldi LM, Roos RP, Devare SG, Casey IM, Maruo Y, Hamada T, Tashiro K. HTLV-I associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p21 antibodies. Ann Neurol 1988. 24:727-731.

[4] 4. Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE. Immunological studies in tropical spastic paraparesis. Ann Neurol 1990, 27:149-156.

[5] 5. Meireles A, Moreira ED Jr, Moreno-Carvalho OA, Badaró R, Melo A. HTLV-I associated myelopathy in Salvador (northeastern Brazil). Arq Neuro-Psiquiat (São Paulo) 1992, 50:189-190.

[6] 6. Melo A, Moura L, Rios S, Machado M, Costa G. Magnetic radiologic imaging in HTLV-I associated myelopathy. Arq Neuro-Psiquiat (São Paulo) 1992, submitted.

[7] 7. Osame M, McArthur JC. Neurologie manifestation of infection with human T cell lymphotropic virus type I. In Asbury AK, McKhann GM, McDonald WI (eds): Diseases of the nervous system: clinical neurobiology. Philadelphia: Saunders, 1992, 1331-1339.

[8] 8. Roman GC. The neuroepidemiology of tropical spastic paraparesis. Ann Neurol 1988, 23 (Suppl):113-130.

[9] 9. Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Kawasaki S. T-lymphocyte alveolitis in HTLV-I associated myelopathy. Lancet 1987, 2:1220.